Vinva Investment Management Boosts Boston Scientific Holdings

The institutional investor increased its stake in the medical device company by 83.2% in the third quarter.

Published on Mar. 8, 2026

Got story updates? Submit your updates here. ›

Vinva Investment Management Ltd. significantly increased its holdings in Boston Scientific Corporation (NYSE:BSX) during the third quarter, according to a recent 13F filing with the Securities and Exchange Commission. The institutional investor added 56,645 shares, bringing its total position to 124,760 shares worth $12.1 million.

Why it matters

Boston Scientific is a major player in the medical device industry, producing a wide range of products used in minimally invasive procedures. Vinva's increased stake suggests the firm sees growth potential in the company, which could signal broader investor confidence in Boston Scientific's business outlook.

The details

Vinva Investment Management lifted its holdings in Boston Scientific by 83.2% in the third quarter, acquiring an additional 56,645 shares. This brought the firm's total position to 124,760 shares, valued at $12.1 million as of the most recent 13F filing.

  • Vinva Investment Management increased its Boston Scientific holdings in the third quarter of 2026.

The players

Vinva Investment Management Ltd

An institutional investor that manages a portfolio of stocks, bonds, and other assets.

Boston Scientific Corporation

A global medical device company that develops and manufactures a broad range of products used in minimally invasive medical procedures.

Got photos? Submit your photos here. ›

The takeaway

Vinva Investment Management's increased stake in Boston Scientific suggests the firm sees strong growth potential in the medical device company, which could signal broader investor confidence in Boston Scientific's business outlook and future performance.